Which Statements Apply to Gout?
The correct answers are a, c, and d. During acute gout attacks, serum uric acid levels may be normal; gouty tophi represent late-stage disease; and elevated uric acid in reproductive-age women warrants investigation for underlying causes.
Statement-by-Statement Analysis
a) During an acute attack, uric acid levels may not be significantly elevated - TRUE
This statement is definitively correct. The EULAR guidelines explicitly state that "during acute attacks serum levels may be normal" with a strength of recommendation of 95 (95% CI, 92-99) 1.
The evidence demonstrates that:
- 14-49% of patients with acute gout have normal serum uric acid levels (≤6 mg/dL) during an attack 2, 3, 4
- Serum uric acid behaves as a negative acute phase reactant, temporarily decreasing during inflammation 1
- The mechanism involves increased renal excretion during acute episodes, with changes correlating to inflammatory markers (CRP, IL-6) 5
Clinical pitfall: Never exclude gout based solely on a normal serum uric acid during an acute presentation. The guidelines emphasize that "serum uric acid levels do not confirm or exclude gout" 1.
b) Large joints are not affected - FALSE
This statement is incorrect. While gout classically affects the first metatarsophalangeal joint (podagra), large joints are commonly involved. The EULAR guidelines note that acute gout attacks affect "the midfoot, ankle, knee, wrist, fingers, and elbow joints" 6. The knee is specifically mentioned as a common site after the foot and ankle 7. Gout can affect virtually any joint, including axial joints in rare cases 6.
c) Gouty tophi are a late finding - TRUE
This statement is correct. The evidence clearly demonstrates tophi as markers of chronic, advanced disease:
- Tophi indicate progression to the chronic tophaceous gout phase, which follows the asymptomatic and acute/intercritical phases 8, 6, 9
- In diagnostic studies, tophi had high specificity (0.99) but low sensitivity (0.30 for definite tophi), indicating they appear in established disease but are absent in early gout 1
- The ACR guidelines distinguish treatment approaches based on tophus presence, with tophi indicating "high body urate burden" requiring more aggressive management 10
Tophi represent accumulated monosodium urate crystal deposits that develop after prolonged hyperuricemia and recurrent attacks.
d) In women of reproductive age, elevated uric acid levels require further investigation - TRUE
This statement is strongly supported by the evidence. The EULAR guidelines specifically note that:
- Women have significantly lower mean serum uric acid levels than men 1
- Different diagnostic thresholds should be used for men (>7 mg/dL) versus women (>6 mg/dL), as this improves diagnostic accuracy (likelihood ratio increases from 3.00 to 7.61) 1
- Women with hyperuricemia had a 17-fold increased risk of developing gout compared to normouricemic women (RR 16.90,95% CI 2.21-129.07) 1
Clinical reasoning: Since hyperuricemia is uncommon in premenopausal women (who typically have lower uric acid due to estrogen's uricosuric effect), elevated levels warrant investigation for:
- Secondary causes (renal disease, medications, genetic disorders)
- Underlying metabolic conditions
- Early-onset familial gout (the guidelines recommend investigating renal uric acid excretion in patients with onset under age 25) 1
Key Clinical Takeaways
- Never rely on serum uric acid alone during acute presentations—up to half of patients may have normal levels 2, 3
- Joint aspiration with crystal identification remains the gold standard for definitive diagnosis 11
- Tophi indicate chronic disease requiring aggressive urate-lowering therapy with target <6 mg/dL 8, 10
- Sex-specific thresholds improve diagnostic accuracy, particularly in women 1